Latest Market Research Reports

  In-vitro Toxicology Testing Market Summary The global  in-vitro toxicology testing market  size was estimated at USD 31,029.0 million in 2023 and is projected to reach USD 64,815.2 million by 2030, growing at a CAGR of 11.1% from 2024 to 2030. The growth of the market is attributed to continuous developments in toxicology research and advancement of technologies, which are enabling faster, safer, and more ethical testing processes for evaluating chemical and drug safety. In addition, rising emphasis on development of personalized medicines is further expected to boost the market during the forecast period. Personalized treatment requires accurate toxicity profiling tailored to individual patient groups, which increases the demand for advanced in-vitro assays capable of predicting human-specific responses. Awareness regarding the limitations and challenges associated with traditional toxicology screening methods has been growing, especially regarding high costs, lengthy ...

In-vitro Toxicology Testing Industry Overview The global in-vitro toxicology testing market size was estimated at USD 22.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.7% from 2021 to 2028.  Significant advancements in toxicology science are one of the primary factors driving the market. Also, high costs associated with conventional animal tests and socio-ethical concerns associated with animal tests are anticipated to boost the growth of the market for in-vitro toxicology testing.   As in-vitro toxicology studies can help in minimizing liabilities related to late-stage failure in the drug discovery process, a high number of research studies and drug development programs for COVID-19 are expected to accelerate the market for in-vitro toxicology testing. More than 590 drugs for COVID-19 are in the development program as of November 2020. Such a high number of drug development programs is anticipated to boost the demand for in vitro ...